课题基金 / 基金详情

Assessment of humoral immune function in chronic obstructive pulmonary disease (COPD) patients: an innovative strategy for COPD phenotyping (AiCOP)

Assessment of humoral immune function in chronic obstructive pulmonary disease (COPD) patients: an innovative strategy for COPD phenotyping (AiCOP)
慢性阻塞性肺疾病 (COPD) 患者体液免疫功能的评估：COPD 表型分析的创新策略 (AiCOP)
批准号：
486188
负责人：
Patel Zil
金额：
$1.27万
依托单位：
University of Ottawa
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486188&lang=en
关键词：
Acute Exacerbation Risk Ratio Acute Exacerbations Of Copd (Aecopd) Adaptive Immunity Chronic Obstructive Pulmonary Disease (Copd) Humoral Immunodeficiency Immunoglobulins Inflammation Polysaccharide Vaccine Response Respiratory Infections T-Cell-

项目摘要

项目成果

相关文献

中文摘要
翻译
慢性阻塞性肺疾病（COPD）是一个全球性的健康问题，已被确定为第三大死因。大多数慢性阻塞性肺病患者会经历被称为复发性加重的疾病突发，导致肺活量加速下降
英文摘要
Chronic obstructive pulmonary disease (COPD) is a global health concern that was identified as the 3rd leading cause of death. A majority of COPD patients experience disease flare-ups known as recurrent exacerbations, leading to accelerated decline in lun
期刊论文(0)
专著(0)
科研奖励(0)
会议论文